Search for: "CAMPAIGN/RESPONSIBLE v. FDA" Results 41 - 60 of 150
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Aug 2018, 10:34 am by Rebecca Tushnet
Tobacco campaigns have studied this issue extensively. [read post]
9 Oct 2017, 9:01 pm by Joanna L. Grossman
In 1972, the Court went further and found in Eisenstadt v. [read post]
30 May 2017, 8:30 am by Josh Blackman
This post is the third part of a four-part series on the Fourth Circuit’s recent en banc decision in IRAP v. [read post]
27 Apr 2017, 1:30 am by Thaddeus Mason Pope, JD, PhD
Kline School of Law, Taming Pharma with Benefit CorporationsDmitry Karshtedt, The George Washington University Law School, Regulating ‘Evergreening’: The FDA's Role in the Creation of Balanced Rights for Pharmaceutical ImprovementsMichael Sinha, Brigham and Women's Hospital and Harvard Medical School, Legal Approaches to Ensuring Timely Generic Drug AvailabilityRebecca Wolitz, Stanford Law School, Patents, Preemption, and Price-Gouging Teaching Session 1G – Room… [read post]
9 Oct 2016, 9:01 pm by Ronald D. Rotunda
In April 2010, the Institute of Medicine urged the FDA to regulate the amount of salt that food manufacturers use in their products; New York City Mayor Michael Bloomberg convinced 16 companies to do so voluntarily, with the threat of government regulation in the background.However, recent science does not support the common assumption about salt. [read post]
13 Jun 2016, 8:04 am by Rebecca Tushnet
  FDA’s regulation of promotion of off-label uses, for example. [read post]